Literature DB >> 6344749

Prostaglandins, glucose homeostasis, and diabetes mellitus.

R P Robertson.   

Abstract

Prostaglandins of the E series are implicated as regulators of glucose homeostasis because of their effects on glucose production and secretion of insulin and glucagon. PGE is postulated to play a role in the pathophysiology of insulin secretion in adult-onset (Type II) diabetes mellitus. Evidence supporting this hypothesis includes the demonstration that PGE inhibits glucose-induced acute insulin responses in normal humans. Moreover, drugs that inhibit synthesis of PGE improve abnormal insulin secretion in human subjects with Type II diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344749     DOI: 10.1146/annurev.me.34.020183.000245

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  10 in total

1.  Immunoprecipitation of antigen-associated [32P]-labelled nucleic acids from Crohn's disease mesenteric lymph nodes.

Authors:  P D Butcher; J J McFadden; A M Murray; J Hermon-Taylor
Journal:  Br J Exp Pathol       Date:  1985-12

Review 2.  Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling.

Authors:  Bethany A Carboneau; Richard M Breyer; Maureen Gannon
Journal:  J Cell Commun Signal       Date:  2017-01-28       Impact factor: 5.782

Review 3.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

4.  Complex Feline Disease Mapping Using a Dense Genotyping Array.

Authors:  Isabel Hernandez; Jessica J Hayward; Jeff A Brockman; Michelle E White; Lara Mouttham; Elizabeth A Wilcox; Susan Garrison; Marta G Castelhano; John P Loftus; Filipe Espinheira Gomes; Cheryl Balkman; Marjory B Brooks; Nadine Fiani; Marnin Forman; Tom Kern; Bruce Kornreich; Eric C Ledbetter; Santiago Peralta; Angela M Struble; Lisa Caligiuri; Elizabeth Corey; Lin Lin; Julie Jordan; Danny Sack; Adam R Boyko; Leslie A Lyons; Rory J Todhunter
Journal:  Front Vet Sci       Date:  2022-06-16

5.  Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease.

Authors:  Bo Zhang; Yuzhou Wan; Xuefeng Zhou; Haojun Zhang; Hailing Zhao; Liang Ma; Xi Dong; Meihua Yan; Tingting Zhao; Ping Li
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

6.  The EP3 Receptor: Exploring a New Target for Type 2 Diabetes Therapeutics.

Authors:  Joshua C Neuman; Michelle E Kimple
Journal:  J Endocrinol Diabetes Obes       Date:  2013 Jul-Sep

Review 7.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

8.  Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes.

Authors:  Tumpa Dutta; High Seng Chai; Lawrence E Ward; Aditya Ghosh; Xuan-Mai T Persson; G Charles Ford; Yogish C Kudva; Zhifu Sun; Yan W Asmann; Jean-Pierre A Kocher; K Sreekumaran Nair
Journal:  Diabetes       Date:  2012-03-13       Impact factor: 9.461

9.  Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.

Authors:  Michelle E Kimple; Mark P Keller; Mary R Rabaglia; Renee L Pasker; Joshua C Neuman; Nathan A Truchan; Harpreet K Brar; Alan D Attie
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

10.  Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.

Authors:  Harpreet K Sandhu; Joshua C Neuman; Michael D Schaid; Sarah E Davis; Kelsey M Connors; Romith Challa; Erin Guthery; Rachel J Fenske; Chinmai Patibandla; Richard M Breyer; Michelle E Kimple
Journal:  Pharmacol Res Perspect       Date:  2021-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.